Skip to content

Polyphenol-Rich Snack Consumption during Endurance Exercise Training Improves Nitric Oxide Bioavailability but does not Improve Exercise Performance in Male Cyclists: A Randomised Controlled Trial.

PMID 40321836 (2025): taper — Time-trial performance (study note for endurance athletes).

Last updated/Feb 23, 2026, 10:34 PM

Study note • PMID 40321836

Polyphenol-Rich Snack Consumption during Endurance Exercise Training Improves Nitric Oxide Bioavailability but does not Improve Exercise Performance in Male Cyclists: A Randomised Controlled Trial.

Current developments in nutrition2025 • DOI 10.1016/j.cdnut.2025.106006
Evidence C68/100
Action 2: Consider

Worth trying if it fits your goal and context.

ELI5

In plain language

To determine whether AGC consumption improved physiological responses and endurance cycling time-trial performance in response to training. (randomized trial; trained cyclists).

The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: To determine whether AGC consumption improved physiological responses and endurance cycling time-trial performance in response to training.
  • The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions.
  • Population: trained cyclists.
  • Protocol cues: abstract may omit dose/timing; use the full paper to replicate accurately.

Protocol

Protocol (as reported)

  • Intervention/exposure: taper (vs comparison group).
  • Dose/time/duration: abstract doesn’t include enough detail; use the full paper’s methods section.
  • Outcomes: Time-trial performance.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it helps, and who should skip it

Who it helps

  • Athletes similar to the study population (trained cyclists) working on tapering.
  • Athletes who can measure Time-trial performance with a repeatable workout or time-trial effort.

Who should skip

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: randomized trial.
  • Population: trained cyclists.
  • Comparator: comparison group.
  • Outcomes measured: Time-trial performance.
  • Source: PubMed PMID 40321836 (2025) — Current developments in nutrition.

Results excerpt

What the abstract reports

Compared to LT, 5CTT performance was impaired at HT (d = -0.27, P = 0.01) and improved at T (d = 0.79, P < 0.001), with no difference between treatments (P > 0.81).

Note: excerpts are short; for full context, read the paper.

Limits

Limitations & bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Coaching beta

Get a plan that adapts to your life.

Join the 26weeks.ai TestFlight beta for adaptive coaching, recovery-aware adjustments, and race-week reminders.

Keep going

Sources